AGTC Genomics Strengthens Regional Expansion Through Strategic Engagement in the Philippines

AGTC Genomics is pleased to announce a strategic engagement with AIMA Life Solutions Inc. and St. Frances Cabrini Medical Center, Inc., Philippines, marking an important step in advancing precision medicine and expanding AGTC’s regional footprint in Southeast Asia. The high-level discussion focused on translating advanced genomics into scalable, clinically impactful solutions within the Philippine healthcare ecosystem.

The session was represented by Mr. Teow Kok Sin, Senior Business Development Manager, and Dr. Boon Shing Tan, Chief Technology Officer of AGTC Genomics. Dr. Tan delivered a keynote outlining AGTC’s end-to-end genomics capabilities, including clinical-grade sequencing, bioinformatics, and precision diagnostics, and how these technologies can support data-driven clinical decision-making, improve patient outcomes, and enable sustainable healthcare innovation.

St. Frances Cabrini Medical Center, a reputable tertiary care institution in the Philippines, brings strong clinical infrastructure, an established patient base, and a proven commitment to clinical excellence. Its readiness to adopt advanced diagnostics positions it as a potential anchor partner for precision medicine implementation and future clinical programmes.

AIMA Life Sciences, a leading regional life sciences organisation, played a pivotal role in facilitating this engagement. With deep market knowledge, regulatory familiarity, and strong institutional relationships, AIMA provides a critical bridge for market entry, localisation, and commercial scaling of advanced medical technologies in the Philippines.

This engagement reflects a shared vision to build a robust precision medicine ecosystem, combining AGTC Genomics’ proprietary technologies and clinical genomics expertise with strong local partners. It also underscores AGTC’s strategy to expand through capital-efficient partnerships, hospital-based implementation models, and regionally scalable platforms.

AGTC Genomics views the Philippines as a high-growth market for precision diagnostics and personalised medicine. The company looks forward to advancing discussions with AIMA Life Sciences and St. Frances Cabrini Medical Center toward structured collaborations that create long-term clinical value, sustainable revenue streams, and regional leadership in precision healthcare.